David Dean Halbert compensation by year
Caris Life Sciences Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $764,918 |
| Bonus | $3,259,311 |
| Stock awards | $15,400,569 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $925,773 |
| Total | $20,350,571 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Caris Life Sciences, Inc. DEF 14A filed April 23, 2026, accession 0002019410-26-000032, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Caris Life Sciences, Inc. filed document, accession 0002019410-26-000032. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.
Caris Life Sciences’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Dean Halbert · this page | Founder, Chairman and Chief Executive Officer | $20,350,571 |
| David Spetzler | President | $11,583,227 |
| J. Russel Denton | Senior Vice President, General Counsel and Secretary | $5,354,614 |
Board service
Caris Life Sciences board · FY2025How this board is paid
Company policy: Caris Life Sciences pays directors a $50,000 cash retainer and $300,000 in equity. As stated in Caris Life Sciences's FY2025 proxy.
The full Caris Life Sciences compensation record
free company briefThis page is one person within Caris Life Sciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Caris Life Sciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Caris Life Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order CAI
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.